Detalles de la búsqueda
1.
Discovery and Optimization of Potent and Orally Available CTP Synthetase Inhibitors for Use in Treatment of Diseases Driven by Aberrant Immune Cell Proliferation.
J Med Chem
; 65(24): 16640-16650, 2022 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36449304
2.
CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.
Arthritis Res Ther
; 17: 234, 2015 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26335795
Resultados
1 -
2
de 2
1
Próxima >
>>